Mission: To promote and accelerate early phase clinical development of novel biotherapeutics by building matrix partnerships between interdisciplinary and inter-institutional laboratory and clinical investigators
Goals include:
- To provide a centralized and accessible translational infrastructure available to academic investigators from all Penn Institutions and CHOP that will support and enable bench to bedside research.
- To facilitate interaction across areas of diversified experience and range of therapeutic modalities towards cross-disciplinary clinical development.
- To train new and junior investigators, in part through educational modules, to promote the field of translational research in novel biotherapeutics.
- To support the bioengineering of devices and processes for optimal delivery and targeting of therapeutics
- To advance the testing of promising cellular and gene therapeutics into later stage clinical development
- To establish the University of Pennsylvania and CHOP as leaders in translational research in the U.S.
PINB Co-Directors
- Carl June, MD - Professor, Department of Pathology and Laboratory Medicine; Director of Translational Research of the Abramson Cancer Center
- Dennis Discher, PhD - Professor, School of Engineering and Applied Science, Department of Chemical & Biomolecular, Mechanical, and Bio-Engineering
- General inquiries can be sent to pinb@pobox.edu
|
